2013
DOI: 10.1016/j.yrtph.2013.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Potency matters: Thresholds govern endocrine activity

Abstract: Whether thresholds exist for endocrine active substances and for endocrine disrupting effects of exogenous chemicals has been posed as a question for regulatory policy by the European Union. This question arises from a concern that the endocrine system is too complex to allow estimations of safe levels of exposure to any chemical with potential endocrine activity, and a belief that any such chemical can augment, retard, or disrupt the normal background activity of endogenous hormones. However, vital signaling … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
45
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 52 publications
(46 citation statements)
references
References 28 publications
1
45
0
Order By: Relevance
“…Thus, the absence of a non-monotonic dose response has been conclusively shown. This is in line with more general evidence that thresholds do exist for endocrine-related effects (Borgert et al 2013;EFSA Scientific Opinion 2013;Borgert et al 2012;Caldwell et al 2012). The existence of threshold doses was recently also shown for the anti-androgenic drug flutamide in a pre-and postnatal in vivo study in Wistar rats (Fussell et al 2015).…”
Section: Discussionsupporting
confidence: 79%
“…Thus, the absence of a non-monotonic dose response has been conclusively shown. This is in line with more general evidence that thresholds do exist for endocrine-related effects (Borgert et al 2013;EFSA Scientific Opinion 2013;Borgert et al 2012;Caldwell et al 2012). The existence of threshold doses was recently also shown for the anti-androgenic drug flutamide in a pre-and postnatal in vivo study in Wistar rats (Fussell et al 2015).…”
Section: Discussionsupporting
confidence: 79%
“…Since the release of this report, debates have continued between researchers who support its conclusions and those who oppose them. Borgert et al (2013), as typical examples of opposition to the conclusions of the report, argue that potency differences, laws of mass action, and the basic design and physiological functions of the endocrine system require and ensure the presence of thresholds. Supporters of the report such as Gore et al 2015counter that receptor down-regulation, when hormones are present in high concentrations, bind to their receptors, and decrease receptor number, leads to non-monotonic dose response resulting in fewer available receptors and a natural shift in the receptor-mediated response.…”
Section: Discussionmentioning
confidence: 93%
“…First and foremost, as discussed by Borgert et al (2013), thresholds govern endocrine activity, and even though activities may be observed from in vitro estrogen assays, and EARs could theoretically be calculated, substances with low potencies are likely not to be biologically active in vivo. Thus, in addition to developing an REEAQ cutoff value for deprioritization, consideration should also be given to developing activity cut off values for each hormonal system.…”
Section: Potential Future Uses Of the Reeaq Methodology For Androgenmentioning
confidence: 99%
“…This proposed exposure:activity profiling approach reflects standardization tools used historically in toxicology, such as dioxin toxicity equivalence factors and environmental estrogen equivalents (Giesy et al, 2002;Van den Berg et al, 1998, but goes beyond toxicity equivalence by incorporating exposure information rather than relying solely on a relative measure of potency or toxicity. Accordingly, the priority status or score of a chemical would reflect both exposure and potency (Borgert et al, 2012(Borgert et al, , 2013. This score would be presented relative to that of a chosen reference chemical to provide appropriate context.…”
Section: Introductionmentioning
confidence: 99%